abstract |
The present invention provides MDM2 inhibitors of formula (I) compounds, (I) Wherein the variables are defined above and the compound is particularly useful as a therapeutic agent for the treatment of cancer. The present invention also relates to pharmaceutical compositions containing MDM2 inhibitors. |